____________________________________
Industrial Liaison Group:
Tel: +44 (0) 1235 778797
E-mail: industry@diamond.ac.uk
If you are an academic user of fragment screening, further information is available to help you access Xchem.
Following the emergence of the new coronavirus SARS-CoV-2 in late 2019 which quickly developed into a pandemic, the race soon began to discover more about the virus and prevent its spread.
Building on the knowledge gained from the SARS outbreak in 2003, it is hoped that by studying the structure of the proteins in SARS-CoV-2 scientists will identify potential lead compounds and develop therapies to prevent viral infection and replication.
In the past two decades, fragment based drug discovery has emerged as a powerful method to discover and develop new drugs. Such strategy relies on the identification of low molecular weight compounds that bind weakly to a target. The structural information gained on fragment-target complexes provides an excellent starting point for the development of potent and selective drugs.
Read more...
Diamond Light Source is the UK's national synchrotron science facility, located at the Harwell Science and Innovation Campus in Oxfordshire.
Copyright © 2022 Diamond Light Source
Diamond Light Source Ltd
Diamond House
Harwell Science & Innovation Campus
Didcot
Oxfordshire
OX11 0DE
Diamond Light Source® and the Diamond logo are registered trademarks of Diamond Light Source Ltd
Registered in England and Wales at Diamond House, Harwell Science and Innovation Campus, Didcot, Oxfordshire, OX11 0DE, United Kingdom. Company number: 4375679. VAT number: 287 461 957. Economic Operators Registration and Identification (EORI) number: GB287461957003.
Industrial Liaison Office
